Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and Docetaxel in advanced gastric cancer
NCT01238055Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2008
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in gastric cancer (GC), sponsored by Samsung Medical Center. Started Nov 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01238055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01238055.